|
|
Article: The FDA granted priority review status to Wyeth's NDA.(Pipeline)
- Article from:
- Medical Marketing & Media
- Article date:
- March 1, 2005
CopyrightCOPYRIGHT 2005 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The FDA granted priority review status to Wyeth's NDA for its investigational antibiotic Tygacil (tigecycline) to ...
Related newspaper, magazine, and journal articles:
|
|
Article: Enzon Announces FDA Assigns Priority Review Status ...
Business Wire;
March 23, 2001 ;
700+ words
... ... Administration (FDA) that priority review status has been assigned to Schering ... considered filed with priority review status as of that date. Priority review status provides for FDA action ... January 19, 2001, the FDA granted marketing approval to PEG ...
|
|